In the past decade, the introduction of molecularly targeted agents and immune-checkpoint
inhibitors has led to improved survival outcomes for patients with advanced-stage lung …

Lung cancer is the leading cause of cancer-related death in the world. It is broadly divided
into small cell (SCLC, approx. 15% cases) and non-small cell lung cancer (NSCLC, approx …

Importance Personalized medicine based on tumor profiling and identification of actionable
genomic alterations is pivotal in cancer management. Although tissue biopsy is still …

Background Low-dose chest CT screening for lung cancer has become a standard of care in
the United States in the past few years, in large part due to the results of the National Lung …

Background Lung cancer screening using low-dose CT (LDCT) was shown to reduce lung
cancer mortality by 20% in the National Lung Screening Trial. Methods The pilot UK Lung …

Lung cancer remains the leading cause of cancer mortality in the United States. Lung cancer
screening (LCS) with low-dose CT reduces mortality among high-risk current and former …

Background Lung cancer is the most common cause of cancer‐related death in the world,
however lung cancer screening has not been implemented in most countries at a population …

Lung cancer causes more deaths than breast, cervical, and colorectal cancer combined.
Nevertheless, population‐based lung cancer screening is still not considered standard …

Background Low-dose chest CT screening for lung cancer has become a standard of care in
the United States, in large part because of the results of the National Lung Screening Trial …

Rationale: Low uptake of low-dose computed tomography (LDCT) lung cancer screening,
particularly by current smokers of a low socioeconomic position, compromises effectiveness …